Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ___________________________ (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number 001-42011 PACS Group, Inc. (Exact name of registrant as specified in its ch ...

PACS Group, Inc. (PACS) came out with quarterly earnings of $0.43 per share, missing the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.25 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -9.47%. A quarter ago, it was expected that this company would post earnings of $0.46 per share when it actually produced earnings of $0.32, delivering a surprise of -30.43%.Over the last four quarters, the compan ...

Financial Data and Key Metrics Changes - Revenue for Q4 2025 was $1.36 billion, up approximately 12% year-over-year, while total revenue for the full year 2025 was $5.29 billion, representing a 29% increase over 2024 [23][24] - Net income for Q4 was $59.8 million, and for the full year, it was $191.5 million, with diluted earnings per share at $1.22 [23][24] - Adjusted EBITDAR for Q4 was $237.7 million, and adjusted EBITDA was $142.1 million, with full-year adjusted EBITDAR at $883.9 million and adjusted EBITDA at $505 million [23][24] Business Line Data and Key Metrics Changes - Total occupancy for the year averaged 89.1%, with mature facilities averaging 94.9% occupancy, up from 94.4% the previous year [24][26] - Ramping facilities averaged 86.3% occupancy, down from over 93% in the prior year, reflecting the transition of facilities into ramping status [24][26] - New facilities averaged 81.1% occupancy compared to 82.8% in 2024, indicating ongoing stabilization efforts [25][26] Market Data and Key Metrics Changes - PACS operates 321 facilities across 17 states, caring for over 31,700 patients daily, supported by over 47,000 team members [7][18] - The company has a total of 35,379 operating beds, including 32,854 skilled nursing beds and 2,525 assisted living beds [18] Company Strategy and Development Direction - The company aims to continue integrating and optimizing its expanded portfolio while investing in people and clinical capabilities [9][22] - PACS plans to pursue selective acquisitions and maintain a disciplined capital allocation strategy to support long-term shareholder value [8][9] - The company is positioned as a consolidator in the fragmented skilled nursing industry, focusing on quality care and operational excellence [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for 2026, expecting steady organic growth and disciplined execution [5][30] - The company anticipates revenue for 2026 to be in the range of $5.65 billion to $5.75 billion, representing nearly an 8% growth over 2025 [29][30] - Adjusted EBITDA for 2026 is expected to be between $555 million and $575 million, indicating a projected growth of almost 12% over 2025 [29][30] Other Important Information - The company maintains a strong balance sheet with a net leverage of approximately 0.3x, providing financial flexibility for growth strategies [8][28] - PACS has invested significantly in its administrator-in-training program to ensure a strong leadership pipeline [8][21] Q&A Session Summary Question: Discussion on payer conversations and share gain opportunities - Management highlighted that as facilities improve quality metrics, they become attractive partners for insurers, leading to stronger contract negotiations [34][35] Question: Details on the M&A pipeline - The company expects to acquire about 5 facilities per quarter in 2026, focusing on underperforming assets [37] - The pipeline is robust, with a strategic approach to evaluating deals [38] Question: Potential for more de novo activity - While acquisitions remain the primary growth strategy, management acknowledged opportunities for de novo developments in certain states [41][42] Question: Observations on pricing in M&A opportunities - Management noted that while prices have increased due to inflation, they are starting to plateau, allowing for selective acquisitions [43][44]

PACS Group (NYSE:PACS) Q4 2025 Earnings call February 26, 2026 05:30 PM ET Company ParticipantsBenjamin Hendrix - VPJason Murray - Co-Founder, Chairman, and CEOJosh Derksen - President and COOMark Hancock - Executive Vice Chairman and Interim CFOConference Call ParticipantsDavid MacDonald - Managing Director and Senior Equity Research AnalystOperatorGreetings. Welcome to PACS Group Fourth Quarter, Full Year 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-a ...

PACS Group (NYSE:PACS) Q4 2025 Earnings call February 26, 2026 05:30 PM ET Speaker5Greetings. Welcome to PACS Group Fourth Quarter, Full Year 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star and the number 0 on your telephone keypad. Please note this conference is being recorded. I will now turn the conference over to ...

2025 Earnings Presentation February 2026 1 Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this presentation other than statements of hist ...

PACS Group, Inc. Reports Fiscal Year and Fourth Quarter 2025 Results Conference Call and Webcast Scheduled for Today, February 26, 2026, at 5:30 pm ET. SALT LAKE CITY, Utah, February 26, 2026 – PACS Group, Inc. (NYSE: PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the fiscal year and fourth quarter of 2025. Full Year 2025 Financial Highlights Fourth Quarter 2025 Financial Highli ...

Core Viewpoint - PACS Group, Inc. plans to release its fiscal year and fourth quarter 2025 financial results on February 26, 2026, after market close [1] Financial Results Announcement - The financial results will be discussed in a management call scheduled for February 26, 2026, at 5:30 p.m. ET [1]

Core Insights - PACS Group, Inc. has acquired three post-acute care facilities, two in Alaska and one in Idaho, totaling 230 beds [1][2] - The acquisitions include real estate for the two Alaska facilities, while the Idaho facility will operate under a lease [2] - This expansion increases PACS' portfolio to 324 communities across 17 states, with nearly 36,000 beds [3] Company Strategy - The company focuses on disciplined growth in the post-acute care sector as part of its operating and investment strategy [3] - Key elements of the growth strategy include expanding operational footprint and selectively increasing real estate ownership [3] - PACS aims to revolutionize post-acute care nationally, enhancing care delivery and long-term performance in strong market fundamentals [3] Company Overview - PACS Group, Inc. is a holding company investing in post-acute healthcare facilities and services, founded in 2013 [4] - It operates 324 post-acute care facilities serving over 31,000 patients daily [4] - The company has been recognized as one of Utah's Best Companies to work for in 2022 and 2023, and ranked among Utah's Fastest Growing Companies [4]

Company Overview - PACS Group is a leading provider in the post-acute healthcare sector, offering a diversified portfolio of senior care and assisted living facilities, employing tens of thousands of professionals to deliver integrated care solutions [6] - The company generates revenue primarily from healthcare and related ancillary services, targeting seniors and individuals requiring post-acute care [9] - As of January 15, PACS shares were priced at $39.37, reflecting a significant increase of 184.9% over the past year, outperforming the S&P 500 by 168.16 percentage points [3] Financial Performance - PACS Group reported a total revenue of $5.14 billion and a net income of $169.04 million for the trailing twelve months (TTM) [4] - The company posted third-quarter revenue of $1.34 billion, representing a year-over-year increase of 31%, with adjusted EBITDA of $131.5 million and operating cash flow exceeding $400 million for the first nine months of the year [11] - Occupancy rates at mature facilities remain near 95%, significantly above the industry average of approximately 80% [11] Recent Developments - Crewe Advisors disclosed the acquisition of 1,035,747 shares of PACS Group, with an estimated transaction value of $22.72 million, increasing its holdings to a total value of $82.45 million, a net increase of $67.19 million from the prior quarter [2] - Following the acquisition, PACS Group now represents 7.3% of Crewe Advisors' 13F assets, indicating a strong commitment to the stock [3][8] - The recent capital inflow into PACS shares, despite their substantial price increase, suggests investor confidence in the company's fundamentals rather than a mere momentum chase [11]